Company Announcements Affymetrix entered into an agreement in October 2011 with the Broad Institute to chart the genomic changes involved in more than 20 types of cancer as part of the Broad’s work on the Cancer Genome Atlas. Using Affymetrix’s Genome-Wide Human SNP 6.0 Array, 13,500 cancer samples will be processed. In November 2011, Affymetrix […]
Company Announcements De Novo Software and ChemoMetec signed a comarketing agreement in October 2011. Nexcelom Bioscience signed a licensing agreement with De Novo Software in October 2011. Partec agreed in November 2011 to sell De Novo Software’s FCS Express software with its CyFlow Cube instrument and to resell the software worldwide. Synthetic biology firm Intrexon […]
Company Announcements New England Biolabs (NEB) agreed in October 2011 to distribute the Single Cell Whole Genome Amplification Kit, which uses Rubicon Genomics’ amplification technology. This is the first NEB product targeted at the single-cell amplification market. WaferGen Biosystems CEO and President Alnoor Shivji resigned in October 2011 but remains chairman. An Office of the […]
Company Announcements ArcticZymes signed a new supply agreement with Affymetrix for its Shrimp Alkaline Phosphatase enzyme covering September 2011 through December 2017. Affymetrix previously held exclusive distribution rights. GE Healthcare Life Sciences exclusively licensed the patent and know-how from Affitech in October 2011 for products containing recombinant Protein L. EMD Millipore will be the initial […]
Company Announcements DNAnexus secured $15 million in October 2011 in second round funding led by Google Ventures and TPG Biotech. The company also entered into a technology collaboration with Google to provide an archive of publicly available DNA data through a Sequence Read Archive site hosted by Google Cloud Storage. Elsevier and PerkinElmer in November […]
Company Announcements The National Institute of Bioprocessing Research and Training, Ireland, and GE Healthcare Life Sciences announced a joint research collaboration in September 2011 to develop new, robust and reproducible biochemical assays for the analysis of the biological activity of therapeutic monoclonal antibodies. An investment of $0.5 million will be made in the first year […]
The life science instrumentation (LSI) market encompasses a broad spectrum of technologies grouped into a dozen categories. LSI technologies range from mature, multibillion dollar markets to high-growth, burgeoning technology segments. Overall, the LSI market is the largest technology sector in the analytical instrument market, accounting for about a quarter of total sales. The LSI market […]
The lab equipment market, as defined by IBO, consists of eight categories of techniques. The overall market totaled nearly $2.5 billion in 2011. With a 2012 growth rate of more than 4%, the market is expected to increase by $100 million by the end of 2012. While laboratory equipment of various types is found in […]
PCR has been around for more than 25 years. As bench space becomes more scarce, the demand for more miniaturized PCR systems has grown. Handheld and portable PCR systems, which were introduced to the market in the early 2000s, add a variety of applications not possible with benchtop PCR systems. In vitro diagnostics and point-of-care […]
Due to the IBO January 15, 2012, forecast issue, a condensed version of the third-quarter IBO Lab Equipment/Consumables Index is presented in this issue. Third-quarter revenues for the Index grew 6.4%, 4.2% organically, to $3,834.8 million. Operating profits rose 4.9% to $707.2 million. Adjusted operating margin improved 50 basis points to 17.7% of sales. Kewaunee […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
